Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00274625 · ClinicalTrials.gov registry record · NA

Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery

A NA study of Obesity and Hernia, sponsored by Cook Group Incorporated.

Completed
Registry status
NA
Development phase
402
Enrollment target
2
Study locations

NCT00274625 is a NA study of Obesity and Hernia that has completed, run by Cook Group Incorporated. The registered enrollment target is 402 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00274625, a NA study of Obesity and Hernia, has completed, sponsored by Cook Group Incorporated.

COMPLETED
Registry status
NA
Development phase
402 participants
Enrollment target
2
Study locations

Study Summary

The primary objective is to compare the effectiveness of the Surgisis Gold Graft to suture closure alone in preventing an incisional hernia after open bariatric surgery.

Conditions Studied

Interventions

  • PROCEDURE Control
  • DEVICE Surgisis Gold Graft

Study Locations (2)

Minnesota

  • Mayo Clinic Foundation - Rochester

Virginia

  • St. Mary's Medical - Richmond

Trial Details

FieldValue
Enrollment Target 402 participants
Start Date 2005-08
Est. Completion 2012-09
Phase NA

Sponsor

Cook Group Incorporated

31 total trials

What the Registry Record Tells You About NCT00274625

The ClinicalTrials.gov registry entry for NCT00274625 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower). The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT00274625 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Virginia.

Frequently Asked Questions

What is clinical trial NCT00274625 about?

NCT00274625 is a clinical study titled "Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery". The primary objective is to compare the effectiveness of the Surgisis Gold Graft to suture closure alone in preventing an incisional hernia after open bariatric surgery.

What is the current status of trial NCT00274625?

This trial is currently completed. It is a NA study. The enrollment target is 402 participants. The study started on 2005-08. Estimated completion is 2012-09.

What conditions does trial NCT00274625 study?

This clinical trial studies the following conditions: Obesity, Hernia.

What interventions are being tested in trial NCT00274625?

The interventions under investigation include: Control (PROCEDURE), Surgisis Gold Graft (DEVICE).

Who is sponsoring clinical trial NCT00274625?

This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00274625 being conducted?

This trial has 2 study locations across Minnesota, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.